Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RT-01 in Advanced Solid Tumors
NCT05205408Phase 1Unknown
- Sponsor
- First Affiliated Hospital of Bengbu Medical University
- Start
- Feb 2022
- Primary completion
- Jun 2023
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
Phase 1, open-label trial of RT-01 in solid tumor (advanced stage), sponsored by First Affiliated Hospital of Bengbu Medical University. Primary endpoint: Dose Limiting Toxicities at 28 days. Status: unknown.
02
Drugs
RT-01
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT05205408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05205408.